Capsulomics, Inc Dba Previse

CLIA Laboratory Citation Details

2
Total Citations
4
Total Deficiencyies
4
Unique D-Tags
CMS Certification Number 21D2256153
Address 1450 S Rolling Road Suite 3 013, Halethorpe, MD, 21227
City Halethorpe
State MD
Zip Code21227
Phone(877) 844-4487

Citation History (2 surveys)

Survey - January 24, 2025

Survey Type: Standard

Survey Event ID: DJE411

Deficiency Tags: D6149 D5311 D5403

Summary:

Summary Statement of Deficiencies D5311 SPECIMEN SUBMISSION, HANDLING, AND REFERRAL CFR(s): 493.1242(a) The laboratory must establish and follow written policies and procedures for each of the following, if applicable: (1) Patient preparation. (2) Specimen collection. (3) Specimen labeling, including patient name or unique patient identifier and, when appropriate, specimen source. (4) Specimen storage and preservation. (5) Conditions for specimen transportation. (6) Specimen processing. (7) Specimen acceptability and rejection. (8) Specimen referral. This STANDARD is not met as evidenced by: Based on review of the polymerase chain reaction (PCR) testing worksheets and interview with the general supervisor (GS), the laboratory failed to ensure that a specimen stability study was performed to establish that a treated specimen could be frozen, thawed, retested and provide accurate test results after the initial PCR testing was performed and failed. Findings: 1. During the review of the PCR worksheets, the GS stated that sometimes the PCR testing for one of the four genes will fail and they will defrost the frozen specimen and retest that particular gene the next day. 2. The GS was asked if a stability study had been performed for freezing, thawing, and retesting the PCR specimen to verify that the test results would still be accurate. According to the GS, the laboratory had not performed a stability study for freezing, thawing, testing the treated specimen for PCR testing. 3. During the exit interview on 01/09/2025 at 3:30 PM, the GS confirmed that a stability study had not been performed to establish that a specimen could be frozen, thawed, retested and the effects would not impact patient results that were reported and interpreted. D5403 PROCEDURE MANUAL CFR(s): 493.1251(b) The procedure manual must include the following when applicable to the test Statement of Deficiencies (X1) Provider/Supplier/CLIA Identification Number (X3) Date Survey Completed Name of Provider or Supplier Street Address, City, State -- 1 of 2 -- procedure: (1) Requirements for patient preparation; specimen collection, labeling, storage, preservation, transportation, processing, and referral; and criteria for specimen acceptability and rejection as described in 493.1242. (2) Microscopic examination, including the detection of inadequately prepared slides. (3) Step-by-step performance of the procedure, including test calculations and interpretation of results. (4) Preparation of slides, solutions, calibrators, controls, reagents, stains, and other materials used in testing. (5) Calibration and calibration verification procedures. (6) The reportable range for test results for the test system as established or verified in 493.1253. (7) Control procedures. (8)

πŸ”’ Unlock Deficiency Summary

Get full access to the detailed deficiency summary for this facility

One-time payment β€’ Lifetime access

Survey - September 8, 2023

Survey Type: Standard

Survey Event ID: 3X5511

Deficiency Tags: D5453

Summary:

Summary Statement of Deficiencies D5453 CONTROL PROCEDURES CFR(s): 493.1256(d)(3)(iv)(g) Unless CMS Approves a procedure, specified in Appendix C of the State Operations Manual (CMS Pub. 7), that provides equivalent quality testing, the laboratory must-- At least once a day patient specimens are assayed or examined perform the following for-- Each test system that has an extraction phase, include two control materials, including one that is capable of detecting errors in the extraction process; (g) The laboratory must document all control procedures performed. This STANDARD is not met as evidenced by: Based on review of the standard operating procedure manual (SOPM) and interview with the general supervisor (GS), the laboratory failed to run two extraction controls for the laboratory developed methylation specific polymerase chain reaction (PCR) assay. Findings: 1. The laboratory performed a methylation specific PCR assay that included an extraction phase to isolate patient DNA. 2. A gene target for beta-actin was used as an internal reference control and acted as a positive extraction control. 3. The SOPM did not describe a negative extraction control. 4. During the survey on 09 /08/2023 at 2:15 PM, the GS confirmed that the laboratory was not running a negative extraction control through the test system. Statement of Deficiencies (X1) Provider/Supplier/CLIA Identification Number (X3) Date Survey Completed Name of Provider or Supplier Street Address, City, State -- 1 of 1 --

πŸ”’ Unlock Deficiency Summary

Get full access to the detailed deficiency summary for this facility

One-time payment β€’ Lifetime access